abafungin

Uses your system voice; voice and rate in settings.

Q4663245Snapshot

≈ 1 min read

Names in other languages

  • Englishabafungin
  • فارسیآبافونگین
  • shAbafungin
  • СрпскиAbafungin
  • Tiếng ViệtAbafungin
  • العربيةأبافنجين
  • 中文阿巴芬净

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Abafungin (INN) is a broad-spectrum arylguanidines-class antifungal agent with a novel mechanism of action for the treatment of dermatomycoses. Abasol is a topical cream formulation of abafungin by York Pharma.

Abafungin (INN) is a broad-spectrum arylguanidines-class antifungal agent with a novel mechanism of action for the treatment of dermatomycoses. Abasol is a topical cream formulation of abafungin by York Pharma.

History

Abafungin was first synthesized at Bayer AG, Leverkusen, Germany. A study of H 2 -antagonists related to famotidine, resulted in the discovery of its antifungal properties. Its development seems to have been discontinued in 2009.

Mechanism of action

Unlike imidazole- and triazole-class antifungals, abafungin directly impairs the fungal cell membrane. In addition, abafungin inhibits the enzyme sterol 24-C-methyltransferase, modifying the composition of the fungal membrane. Abafungin has antibiotic activity against gram-positive bacteria as well as sporicidal activity.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1377684648 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.